Large-scale analysis of branchpoint usage across species and cell lines.

The coding sequence of each human pre-mRNA is interrupted, on average, by 11 introns that must be spliced out for proper gene expression. Each intron contains three obligate signals: a 5' splice site, a branch site, and a 3' splice site. Splice site usage has been mapped exhaustively across different species, cell types, and cellular states. In contrast, only a small fraction of branch sites have been identified even once. The few reported annotations of branch site are imprecise as reverse transcriptase skips several nucleotides while traversing a 2-5 linkage. Here, we report large-scale mapping of the branchpoints from deep sequencing data in three different species and in the SF3B1 K700E oncogenic mutant background. We have developed a novel method whereby raw lariat reads are refined by U2snRNP/pre-mRNA base-pairing models to return the largest current data set of branchpoint sequences with quality metrics. This analysis discovers novel modes of U2snRNA:pre-mRNA base-pairing conserved in yeast and provides insight into the biogenesis of intron circles. Finally, matching branch site usage with isoform selection across the extensive panel of ENCODE RNA-seq data sets offers insight into the mechanisms by which branchpoint usage drives alternative splicing.

[1]  Eric T. Wang,et al.  Identification of new branch points and unconventional introns in Saccharomyces cerevisiae , 2016, RNA.

[2]  S. Roman-Roman,et al.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage , 2016, Nature Communications.

[3]  M. Warmuth,et al.  Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point. , 2015, Cell reports.

[4]  Dennis Carson,et al.  Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers , 2015, PLoS Comput. Biol..

[5]  Wilfried Haerty,et al.  Genome-wide discovery of human splicing branchpoints , 2015, Genome research.

[6]  Panagiotis K. Papasaikas,et al.  Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. , 2014, Molecular cell.

[7]  Mukul S. Bansal,et al.  A comparative encyclopedia of DNA elements in the mouse genome , 2014, Nature.

[8]  Yi Zhang,et al.  Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome , 2014, Nature Structural &Molecular Biology.

[9]  M. Warmuth,et al.  Abstract 2932: SF3B1 mutations induce aberrant mRNA splicing in cancer and confer sensitivity to spliceosome inhibition , 2014 .

[10]  Danny A. Bitton,et al.  LaSSO, a strategy for genome-wide mapping of intronic lariats and branch points using RNA-seq , 2014, Genome research.

[11]  Julia Salzman,et al.  Cell-Type Specific Features of Circular RNA Expression , 2013, PLoS genetics.

[12]  A. Awan,et al.  Lariat sequencing in a unicellular yeast identifies regulated alternative splicing of exons that are evolutionarily conserved with humans , 2013, Proceedings of the National Academy of Sciences.

[13]  L. DesGroseillers.  Faculty Opinions recommendation of Natural RNA circles function as efficient microRNA sponges. , 2013 .

[14]  P. Baumann,et al.  Intronic sequence elements impede exon ligation and trigger a discard pathway that yields functional telomerase RNA in fission yeast. , 2013, Genes & development.

[15]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[16]  A. Bowcock,et al.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma , 2013, Nature Genetics.

[17]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[18]  Manolis Kellis,et al.  Interpreting non-coding variation in complex disease genetics , 2012, Nature Biotechnology.

[19]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[21]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[22]  Allison J. Taggart,et al.  Large-scale mapping of branchpoints in human pre-mRNA transcripts in vivo , 2012, Nature Structural &Molecular Biology.

[23]  Aaron A Hoskins,et al.  The spliceosome: a flexible, reversible macromolecular machine. , 2012, Trends in biochemical sciences.

[24]  R. Padgett.  New connections between splicing and human disease. , 2012, Trends in genetics : TIG.

[25]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[26]  C. Hammann,et al.  Secondary structure is required for 3′ splice site recognition in yeast , 2011, Nucleic acids research.

[27]  J. Valcárcel,et al.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. , 2011, Genes & development.

[28]  Christopher W. J. Smith,et al.  Genome-Wide Association between Branch Point Properties and Alternative Splicing , 2010, PLoS Comput. Biol..

[29]  Eric T. Wang,et al.  Analysis and design of RNA sequencing experiments for identifying isoform regulation , 2010, Nature Methods.

[30]  Christopher W. J. Smith,et al.  Four exons of the serotonin receptor 4 gene are associated with multiple distant branch points. , 2010, RNA.

[31]  Duncan J. Smith,et al.  Insights into branch nucleophile positioning and activation from an orthogonal pre-mRNA splicing system in yeast. , 2009, Molecular cell.

[32]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[33]  Soo-Chen Cheng,et al.  Both Catalytic Steps of Nuclear Pre-mRNA Splicing Are Reversible , 2008, Science.

[34]  Duncan J. Smith,et al.  "Nought may endure but mutability": spliceosome dynamics and the regulation of splicing. , 2008, Molecular cell.

[35]  Kinji Ohno,et al.  Human branch point consensus sequence is yUnAy , 2008, Nucleic acids research.

[36]  Tyler S. Alioto,et al.  U12DB: a database of orthologous U12-type spliceosomal introns , 2006, Nucleic Acids Res..

[37]  J. Berglund,et al.  An Extended RNA Binding Site for the Yeast Branch Point-binding Protein and the Role of Its Zinc Knuckle Domains in RNA Binding* , 2006, Journal of Biological Chemistry.

[38]  C. Gooding,et al.  A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones , 2006, Genome Biology.

[39]  C. Gooding,et al.  Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. , 2004, Molecular cell.

[40]  C. Burge,et al.  A computational analysis of sequence features involved in recognition of short introns , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Reed,et al.  An Upstream AG Determines Whether a Downstream AG Is Selected during Catalytic Step II of Splicing , 2001, Molecular and Cellular Biology.

[42]  R. Padgett,et al.  Role of the 3′ Splice Site in U12-Dependent Intron Splicing , 2001, Molecular and Cellular Biology.

[43]  Gary D. Stormo,et al.  Identifying DNA and protein patterns with statistically significant alignments of multiple sequences , 1999, Bioinform..

[44]  C. Gooding,et al.  Polypyrimidine Tract Binding Protein Functions as a Repressor To Regulate Alternative Splicing of α-Actinin Mutally Exclusive Exons , 1999, Molecular and Cellular Biology.

[45]  W. Hess,et al.  Precise branch point mapping and quantification of splicing intermediates. , 1997, Nucleic acids research.

[46]  Christopher W. J. Smith,et al.  Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns , 1993, Molecular and cellular biology.

[47]  S. Liebhaber,et al.  A native RNA secondary structure controls alternative splice-site selection and generates two human growth hormone isoforms. , 1992, The Journal of biological chemistry.

[48]  J. Rossi,et al.  Unexpected point mutations activate cryptic 3' splice sites by perturbing a natural secondary structure within a yeast intron. , 1991, Genes & development.

[49]  M. Goux-Pelletan,et al.  In vitro splicing of mutually exclusive exons from the chicken beta‐tropomyosin gene: role of the branch point location and very long pyrimidine stretch. , 1990, The EMBO journal.

[50]  D. Helfman,et al.  Branch point selection in alternative splicing of tropomyosin pre-mRNAs. , 1989, Nucleic acids research.

[51]  Christopher W. J. Smith,et al.  Mutually exclusive splicing of α-tropomyosin exons enforced by an unusual lariat branch point location: Implications for constitutive splicing , 1989, Cell.

[52]  K. Hall,et al.  Structure of a pre-mRNA branch point/3' splice site region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Gallwitz,et al.  Nuclear pre‐mRNA splicing in the fission yeast Schizosaccharomyces pombe strictly requires an intron‐contained, conserved sequence element. , 1987, The EMBO journal.

[54]  M. Rosbash,et al.  RNA splicing and intron turnover are greatly diminished by a mutant yeast branch point. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Felder,et al.  Yeast pre‐messenger RNA splicing efficiency depends on critical spacing requirements between the branch point and 3′ splice site. , 1986, The EMBO journal.

[56]  P. Sharp,et al.  Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors. , 1984, Science.